Dengue Lurks During Coronavirus Disease-19 Pandemic in Indonesia: A Narrative Review

Wienta Diarsvitri; Retno Budiarti; Pramita Anindya Nugraheni; M. Fathi Ilmawan; Verna Biutifasari

doi:10.3889/oamjms.2020.5328

Authors

Wienta Diarsvitri Department of Community Health, Faculty of Medicine, Universitas Hang Tuah, Surabaya, Indonesia
Retno Budiarti Department of Microbiology, Faculty of Medicine, Universitas Hang Tuah, Surabaya, Indonesia
Pramita Anindya Nugraheni Department of Paediatrics, Faculty of Medicine, Universitas Hang Tuah, Dr. Ramelan Naval Hospital, Surabaya, Indonesia
M. Fathi Ilmawan Department of Internal Medicine, Faculty of Medicine, Universitas Hang Tuah, Surabaya, Indonesia
Verna Biutifasari Department of Clinical Pathology, Faculty of Medicine, Universitas Hang Tuah, Surabaya, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.5328

Keywords:

Dengue, Coronavirus disease-19, Pathogenesis, Clinical manifestations, Clinical pathology findings, Epidemiology

Abstract

BACKGROUND: Most attention and healthcare resources in Indonesia have been geared toward battling the coronavirus (CoV) disease (COVID)-19 pandemic, and less overture has been given to the looming risks of dengue that has been endemic in many areas of Indonesia. Despite related constraints, the Primary Health Cares (PHC) in Indonesia plays an important role in the face of emergency situations.

AIM: This study aimed to review the dengue and COVID-19 infection, clinical manifestations in children and adults, clinical pathology findings, as well as the prevention strategies that could be applied in PHC.

METHODS: This study is a narrative review based on the research articles and reports that were published between 2010 and 2020. A total of 70 articles and reports were obtained and after careful consideration, 58 articles and reports were used as references of this study.

RESULTS: Both dengue virus (DENV) and severe acute respiratory syndrome-CoV (SARS-CoV-2) share the similarity of antigenic structure, common symptoms, and laboratory findings. The immune response in SARS-CoV-2 may cause a cytokine storm, which can increase vascular permeability and organ damage. Secondary infection of DENV with different strains may allow the occurrence of antibody-dependent enhancement. The cross-reactions between SARS-CoV-2 antibodies and DENV antigens may cause false positive on rapid dengue infection serological tests.

CONCLUSION: PHC as the front line of health services has a fundamental role in the crisis situation. The prevention and control of DENV and SARS-CoV-2 infections are based on the mode of transmission and need compliance to the related health protocols.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

Author Biography

Retno Budiarti, Department of Microbiology, Faculty of Medicine, Universitas Hang Tuah, Surabaya, Indonesia

Retno Budiarti is the first author for this manuscript

References

Ministry of Health of the Republic of Indonesia. Recent Situation of Novel Coronavirus (COVID-19). Jakarta: Ministry of Health of the Republic of Indonesia; 2020.

The World Bank. The World Bank in Indonesia. Washington, D.C: The World Bank; 2020. p. 1.

Djalante R, Lassa J, Setiamarga D, Sudjatma A, Indrawan M, Haryanto B, et al. Review and analysis of current responses to COVID-19 in Indonesia: Period of January to March 2020. Prog Disaster Sci. 2020;6:100091. https://doi.org/10.1016/j.pdisas.2020.100091

World Health Organization Indonesia. Coronavirus Disease 2019 (COVID-19) Situation Report-4. Geneva: World Health Organization Indonesia; 2020.

Soepardi J, Brahim R, Hasnawati, Anggraeni ND, Ismandari F. Dengue Hemorrhagic Fever in Indonesia 1968-2009. Bul Jendela Epidemiol. 2010;2:1-13.

Ministry of Health of the Republic of Indonesia. Until July, Dengue Cases in Indonesia Reached 71 Thousand. Jakarta: Ministry of Health of the Republic of Indonesia; 2020. p. 1.

Ministry of Health of the Republic of Indonesia. Recent Situation of Novel Coronavirus (COVID-19). Data Reported Until 9 July 2020. Jakarta: Ministry of Health of the Republic of Indonesia; 2020. Available from: https://www.infeksiemerging.kemkes.go.id/download/Situasi_Terkini_100720.pdf. [Last accessed on 20 Oct 2020].

Agustina R, Dartanto T, Sitompul R, Susiloretni KA, Suparmi MK, Achadi EL, et al. Universal health coverage in Indonesia: Concept, progress, and challenges. Lancet. 2019;393(10166):75-102. https://doi.org/10.1016/s0140-6736(18)31647-7 PMid:30579611

Harapan H, Michie A, Mudatsir M, Sasmono RT, Imrie A. Epidemiology of dengue hemorrhagic fever in Indonesia: Analysis of five decades data from the national disease surveillance. BMC Res Notes. 2019;12(1):350. https://doi.org/10.1186/s13104-019-4379-9 PMid:31221186

Ministry of Health of the Republic of Indonesia. COVID-19 Update until 19 October 2020. Jakarta: Ministry of Health of the Republic of Indonesia; 2020. Available from: https://www.infeksiemerging.kemkes.go.id.

Pulungan AB. The covid-19 pandemic and Asia-Pacific children. Asia Pac J Pediatr Child Health. 2020;3:57-8.

Centers for Disease Control and Prevention. Viral Hemorrhagic Fevers (VHFs). Flavivirus. Atlanta: Centers for Disease Control and Prevention; 2013. p. 1.

Martina BE, Koraka P, Osterhaus AD. Dengue virus pathogenesis: An integrated view. Clin Microbiol Rev. 2009;22(4):564-81. https://doi.org/10.1128/cmr.00035-09 PMid:19822889

de Angel RM, Reyes-del Valle J. Dengue vaccines: Strongly sought but not a reality just yet. PLoS Pathog. 2013;9(10):e1003551. https://doi.org/10.1371/journal.ppat.1003551 PMid:24098108

Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virol J 2019;16(1):69. https://doi.org/10.1186/s12985-019-1182-0 PMid:31133031

Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol. 2020;17(6):613-20. https://doi.org/10.1038/s41423-020-0400-4 PMid:32203189

Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66-70. https://doi.org/10.1016/j.cytogfr.2020.05.002 PMid:32418715

Garcia M, Wehbe M, Lévêque N, Bodet C. Skin innate immune response to flaviviral infection. Eur Cytokine Netw. 2017;28(2):41-51. https://doi.org/10.1684/ecn.2017.0394 PMid:28840835

Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev. 2001;14(4):778-809. https://doi.org/10.1128/cmr.14.4.778-809.2001 PMid:11585785

Cha L, Berry CM, Nolan D, Castley A, Fernandez S, French MA. Interferon-alpha, immune activation and immune dysfunction in treated HIV infection. Clin Transl Immunol. 2014;3(2):e10. https://doi.org/10.1038/cti.2014.1 PMid:25505958

Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91-8. https://doi.org/10.1016/j.jare.2020.03.005 PMid:32257431

Laing K, Hutchinson F. “Immune Responses to Viruses”. London, United Kingdom: British Society for Immunology; 2014. Available from: https://www.immunology.org/public-information/bitesized-immunology/pathogens-and-disease/immuneresponses-viruses. [Last accessed on 20 Oct 2020].

Mak T, Saunders M, Jett B. “Immunity to Infection.” In: Primer to the Immune Response. 2nd ed. Cambridge, Massachusetts: Academic Cell; 2014. p. 295–332.

Pulendran B, Oh JZ, Nakaya HI, Ravindran R, Kazmin DA. Immunity to viruses: Learning from successful human vaccines. Immunol Rev. 2013;255(1):243-55. https://doi.org/10.1111/imr.12099 PMid:23947360

Hasan S, Jamdar SF, Alalowi M, Al Ageel Al Beaiji SM. Dengue virus: A global human threat: Review of literature. J Int Soc Prev Community Dent. 2016;6(1):1-6. https://doi.org/10.4103/2231-0762.175416 PMid:27011925

St John AL. Influence of mast cells on dengue protective immunity and immune pathology. PLoS Pathog. 2013;9(12):e1003783. https://doi.org/10.1371/journal.ppat.1003783 PMid:24367254

Rothman AL, Medin CL, Friberg H, Currier JR. Immunopathogenesis versus protection in dengue virus infections. Curr Trop Med Rep. 2014;1(1):13-20. https://doi.org/10.1007/s40475-013-0009-0 PMid:24883262

Wan SW, Wu-Hsieh BA, Lin YS, Chen WY, Huang Y, Anderson R. The monocyte-macrophage-mast cell axis in dengue pathogenesis. J Biomed Sci. 2018;25(1):77. https://doi.org/10.1186/s12929-018-0482-9 PMid:30409217

Negro F. Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis? Swiss Med Wkly. 2020;150:w20249. https://doi.org/10.4414/smw.2020.20249 PMid:32298458

Ulrich H, Pillat MM, Tárnok A. Dengue fever, covid-19 (SARSCoV-2), and antibody-dependent enhancement (ADE): A perspective. Cytometry A. 2020;19(2):662-7. https://doi.org/10.1002/cyto.a.24047 PMid:32506725

Merad M, Martin JC. Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355-62. https://doi.org/10.1038/s41577-020-0331-4 PMid:32376901

Mubarak A, Alturaiki W, Hemida MG. Middle east respiratory syndrome coronavirus (mers-cov): Infection, immunological response, and vaccine development. J Immunol Res. 2019;2019:6491738. https://doi.org/10.1155/2019/6491738

Cardona-Ospina JA, Arteaga-Livias K, Villamil-Gómez WE, Pérez-Díaz CE, Bonilla-Aldana DK, Mondragon-Cardona A, et al. “Dengue and COVID-19, overlapping epidemics? An analysis from Colombia. J Med Virol. 2020. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26194. [Last accessed on 20 Oct 2020]. PMid:32558962

Pinky L, Dobrovolny HM. Coinfections of the respiratory tract: Viral competition for resources. PLoS One. 2016;11(5):e0155589. https://doi.org/10.1371/journal.pone.0155589 PMid:27196110

Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-87. https://doi.org/10.1093/cvr/cvaa106 PMid:32352535

Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue. Lancet. 2019;393(10169):350-63. https://doi.org/10.1016/s0140-6736(18)32560-1 PMid:30696575

Yan G, Lee CK, Lam LT, Yan B, Chua YX, Lim AY, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis. 2020;20(5):536. https://doi.org/10.1016/s1473-3099(20)30158-4 PMid:32145189

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/s0140-6736(20)30211-7 PMid:32007143

Lokida D, Lukman N, Salim G, Butar DP, Kosasih H, Wulan WN, et al. Diagnosis of COVID-19 in a dengue-endemic area. Am J Trop Med Hyg. 2020;103(3):1220-2. https://doi.org/10.4269/ajtmh.20-0676 PMid:32762798

Lorenz C, Azevedo TS, Chiaravalloti-Neto F. COVID-19 and dengue fever: A dangerous combination for the health system in Brazil. Travel Med Infect Dis. 2020;35:101659. https://doi.org/10.1016/j.tmaid.2020.101659 PMid:32278756

Dong Y, Dong Y, Mo X, Hu Y, Qi X, Jiang F, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. https://doi.org/10.1542/peds.2020-0702 PMid:32179660

de Oliveira Toledo SL, Nogueira LS, das Graças Carvalho M, Rios DR, de Barros Pinheiro M. COVID-19: Review and hematologic impact. Clin Chim Acta. 2020;510:170-6. https://doi.org/10.1016/j.cca.2020.07.016 PMid:32659224

Pimentel GD, Vega MC, Laviano A. High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients. Clin Nutr ESPEN. 2020. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427597/pdf/main.pdf. [Last access on 20 Oct 2020].

Sun S, Cai X, Wang H, He G, Lin Y, Lu B, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174-80. https://doi.org/10.1016/j.cca.2020.04.024 PMid:32339487

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5 PMid:31986264

Centers for Disease Control and Prevention. Dengue vaccine globally. Atlanta: Centers for Disease Control and Prevention; 2019. p. 1.

Kusriastuti R, Sutomo S. Evolution of dengue prevention and control programme in Indonesia. Dengue Bull. 2005;29:1-7.

Ministry of Health of the Republic of Indonesia. Beware of DHF, Prevent with 3M Plus. Jakarta: Ministry of Health of the Republic of Indonesia; 2020. p. 1.

World Health Organization. World Health Organization, and Regional Office for South-East Asia. Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Revised and Expanded ed. SEARO Technical. Geneva: World Health Organization; 2011. p. 212.

World Health Organization. Infection Prevention and Control of Epidemic and Pandemic-prone Acute Respiratory Infections in Health Care. WHO Guidelines. Geneva: World Health Organization; 2014. p. 156.

Liu J, Liao X, Qian S, Yuan J, Wang F, Liu Y, et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020;26(6):1320-3. https://doi.org/10.3201/eid2606.200239 PMid:32125269

World Health Organizaton. Advice on the Use of Masks in the Context of COVID-19. Geneva: World Health Organizaton; 2020. p. 16.

Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564-7. https://doi.org/10.1056/nejmc2004973 PMid:32182409

Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843-4. https://doi.org/10.1001/jama.2020.3786 PMid:32159775

World Health Organization. Transmission of SARS-CoV-2: Implications for infection prevention precautions. Geneva: World Health Organization; 2020.

Sarti TD, Lazarini WS, Fontenelle LF, Almeida AP. What is the role of primary health care in the COVID-19 pandemic? Epidemiol Serv Saude. 2020;29(2):e2020166. PMid:32348404

World Health Organization. Coronavirus Disease (COVID-19) Advice for the Public. Geneva: World Health Organization; 2020. p. 6.

Ministry of Health of the Republic of Indonesia. Minister of Health of the Republic of Indonesia Decree No. HK.01.07/Menkes/382/2020 about Health Protocol for Communities in Public Places and Facilities to Prevent and Control Corona Virus Disease 2019 (COVID-19). Indonesia: Ministry of Health of the Republic of Indonesia; 2020. p. 66.